KETOSTERIL (ketoanalogues), combination of amino acids

NEPHROLOGY - New medicinal product
Opinions on drugs - Posted on Jul 10 2015

Reason for request

Inclusion

No clinical benefit demonstrated in combination with a very low protein diet in chronic renal failure

  

  • KETOSTERIL has Marketing Authorisation, in combination with a very low protein diet (0.4 g/kg/day) in chronic renal failure, to reduce the uraemic syndrome and better control the phosphorous-calcium metabolism.

  • The data from clinical studies having evaluated its efficacy and safety are fragmentary.

  • Its actual benefit is low and does not provide any improvement in the management of patients with chronic renal failure in combination with a very low protein diet.

 

 


Clinical Benefit

Low

-


Clinical Added Value

no clinical added value

-


Therapeutic use

-

Contact Us

Évaluation des médicaments